CD24 and breast carcinoma: The increase might be due to the contribution of miR590-3p to therapy resistance like CD24, as miR590-3p promotes radiotherapy resistance in colorectal cancers.[40] We think that miR590-3p levels might indicate poor pathologic response in breast cancer patients and its further elevation might be a predictive sign of therapy resistance.